Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer

Eur J Cancer. 2000 Sep:36 Suppl 4:S73. doi: 10.1016/s0959-8049(00)00234-3.

Abstract

Tangeretin, a molecule present in citrus fruits and in certain 'natural' menopausal medications, is an effective tumour growth and invasion inhibitor in vitro of human MCF 7/6 breast cancer cells. However, when added to the drinking water of MCF 7/6 tumour-bearing mice it neutralises the beneficial tumour-suppressing effect of tamoxifen. Tangeretin reduces the number of natural killer cells. This may explain why the beneficial suppressive effect of tangeretin on MCF 7/6 cell proliferation in vitro is completely counteracted in vivo.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents, Hormonal / antagonists & inhibitors*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Female
  • Flavones*
  • Flavonoids / pharmacology*
  • Food-Drug Interactions
  • Mammary Neoplasms, Experimental / drug therapy*
  • Mice
  • Tamoxifen / antagonists & inhibitors*
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal
  • Flavones
  • Flavonoids
  • Tamoxifen
  • tangeretin